Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Madrigal Pharmaceuticals Inc MDGL

Healthcare Biotechnology
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-ß (THR-ß) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:MDGL)

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 3 days ago

Madrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra(TM) (resmetirom) for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis

GlobeNewswire 10 days ago

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire April 3, 2024

Madrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering

GlobeNewswire March 18, 2024

Madrigal Pharmaceuticals Announces Proposed Public Offering

GlobeNewswire March 18, 2024

Madrigal Pharmaceuticals Announces FDA Approval of Rezdiffra(TM) (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Moderate to Advanced Liver Fibrosis

GlobeNewswire March 14, 2024

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire March 6, 2024

Madrigal Pharmaceuticals Announces EMA Validation of its Marketing Authorization Application for Resmetirom for the Treatment of NASH/MASH with Liver Fibrosis

GlobeNewswire March 5, 2024

Madrigal Pharmaceuticals Appoints Mardi C. Dier as Chief Financial Officer

GlobeNewswire February 28, 2024
View More News ››

Opinion & Analysis (NDAQ:MDGL)

Biotech with non-statin cholesterol lowering drug poised for significant catalysts in 2018

Streetwise Reports January 11, 2018

Biotech delivers 'great' Phase 2 data in NASH

Streetwise Reports December 11, 2017
View More Opinion ››

Bullboard Posts (NDAQ:MDGL)

MDGL.... Ka Boooooooom

Holy cr*p
Iseneschal - December 19, 2022

WILL RESMETIROM PROVE TO BE A GAMECHANGER IN NASH?

$MDGL   Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) a clinical-stage biopharmaceutical company, announced positive topline...
AviseAnalytics - February 4, 2022

Please have a look

https://www.change.org/p/fda-and-ema-improving-the-public-health?recruiter=1170861947&recruited_by_id=6f0edee0-47cf-11eb-a646...
scarlet1967 - May 26, 2021

$iMIN making moves in Ethereum Crypto !! 🚀🚀🚀🚀🚀

iMining Launches Fractional Staking to Enable Retail Investors to Participate in Ethereum 2.0's Proof-Of-Stake Mining Vancouver...
Saaaa1 - May 6, 2021
View more Bullboard ››

Lancaster Resources Inc.

Lancaster Resources Inc.

Lancaster Resources Inc. is a Canada-based company engaged in exploring lithium and uranium and other critical minerals. The ...
View More »